Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Stephen v liu
Oct 20, 2024, 19:52 |
Blog
Stephen V Liu: Case report in Annals of Oncology of patients with NUT carcinoma responding to lurbinectedin
Stephen V Liu shared a post on X, about recent case report published in Annals…
Oct 20, 2024, 17:47 |
Drugs
Stephen V Liu: Long-term survival with nivolumab and ipilimumab in advanced NSCLC
Stephen V Liu shared on X: "Long-term survival (median f/u 73.7m) with nivolumab and ipilimumab…
Oct 20, 2024, 17:43 |
Blog
Stephen V Liu: Huge potential utility of LB for early stage lung cancer explained by Christian Rolfo
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared on X: “Huge potential…
Oct 20, 2024, 14:51 |
Blog
Stephen V Liu: Ryan Gentzler breaks down adjuvant immunotherapy for NSCLC at DCLung24
Stephen V Liu, Associate Professor of Medicine at Georgetown University, posted on X: "Dr. Ryan…
Oct 20, 2024, 13:22 |
Blog
Christian Rolfo: Starting the DC Lung 2024 with the welcome by Stephen V Liu
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials…
Oct 18, 2024, 16:52 |
Blog
Oncology Brothers: Lung Cancer Highlights from ESMO24 with Stephen V Liu
Oncology Brothers posted on X: "Lung Cancer Highlights ESMO24 with Stephen V Liu Updates on:…
Oct 17, 2024, 20:55 |
Blog
Stephen V Liu: Join us at the Grand Hyatt in Washington, DC for the DC Lung Cancer Conference
Stephen V Liu posted the following on X: “Join us at the Grand Hyatt in…
Oct 16, 2024, 18:00 |
Insight
Stephen V Liu: Is immunotherapy effective for HER2 mutant NSCLC?
Stephen V Liu shared on X a recent paper by Yuki Kato et al. titled…
Oct 14, 2024, 13:40 |
Insight
Retrospective report on EGFR mutant NSCLC transformed to SCLC, suggested by Stephen V Liu
Stephen V Liu shared a post on X: "Retrospective report in European Journal of Cancer on…
Oct 13, 2024, 07:07 |
Blog
Stephen V Liu: Cardiotoxicity of osimertinib in real world population with EGFR NSCLC
Stephen V Liu shared on X: "Cardiotoxicity of osimertinib in real world population with EGFR…
1
2
3
4
5
All:
233
Posts:
1 - 10
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Clinical Trials That Changed the Life of Cancer Patients: Insights from the CEO of EORTC, Dr. Denis Lacombe
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube